Medirom Healthcare Technologies Inc. (MRM) stock
Close on Nov 11, 2026Market cap $2.19MP/E 1.5Yield –
Medirom Healthcare Technologies Inc. grew revenue 21.5% to ¥8.30B over fiscal 2024. Free cash flow was -¥1.40B. At the latest close the market valued the company at ¥346.09M, 1.5 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2024, balances at Jun 30, 2025
Valuation
- Market cap
- ¥346.09M
- P/E ratio
- 1.5
- Price to sales
- 0.04
- Price to book
- 1.43
- Dividend yield
- –
- Free cash flow yield
- -405.41%
Fundamentals
- Revenue
- ¥8.30B
- Net income
- ¥148.76M
- EPS, diluted
- 28.52 JPY
- Free cash flow
- -¥1.40B
Trading
- Previous close
- $0.26
- Open
- $0.26
- Day's range
- $0.26 – $0.30
- Volume
- 5,780
- Average volume (20 days)
- 350,026
- Beta (5 years)
- 0.60
- RSI (14 days)
- 23.7
- Volatility (1 year)
- 73.8%
- Relative volume
- 0.05×
- WACC
- 5.3%
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | MRM | S&P 500 | Difference | MRM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -49.9% | -2.4% | −47.5 pts | ||
| 3 months | -73.6% | -1.2% | −72.5 pts | ||
| Year to date | -85.7% | +12.3% | −98.0 pts | ||
| 1 year | -86.6% | +12.4% | −99.1 pts | ||
| 3 years | -94.3% | +78.8% | −173.1 pts | -61.6% | +21.4% |
| 5 years | -96.1% | +75.2% | −171.3 pts | -47.8% | +11.9% |
| 10 years | -98.3% | +311.1% | −409.4 pts | -33.3% | +15.2% |
Seven years at a glance
Fiscal years 2018 to 2024, JPY
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Medirom Healthcare Technologies filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Medirom Healthcare Technologies
Services-Personal Services
MEDIROM Healthcare Technologies Inc. provides holistic healthcare and wellness services in Japan. The company operates across three segments: Relaxation Salons, Luxury Beauty, and Digital Preventative Healthcare. Through its core relaxation business, primarily branded under Re.Ra.Ku alongside Bell Epoc and Ruam Ruam, it delivers bodywork, stretch therapy, posture alignment, and reflexology. The luxury beauty segment operates high-end hair salons under the ZACC brand. In digital healthcare, the company offers health monitoring and fitness technologies, including its proprietary Lav mobile application, MOTHER Bracelet device, and government-sponsored health guidance programs. Its clientele comprises health-conscious individuals, consumers seeking physical and mental therapy, hair salon visitors, and corporate health insurance providers.
Company profile, executives and historyMedirom Healthcare Technologies stock: common questions
What is Medirom Healthcare Technologies's stock price?
MRM closed at $0.28 on Nov 11, 2026, up 6.01% on the day.
What is Medirom Healthcare Technologies's market cap?
Medirom Healthcare Technologies was worth $2.19M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is MRM's P/E ratio?
MRM trades at 1.5 times earnings, based on diluted earnings per share of 28.52 JPY over fiscal 2024.
How much revenue does Medirom Healthcare Technologies make?
Medirom Healthcare Technologies reported revenue of ¥8.30B for fiscal 2024, up 21.5% from a year earlier.
Does Medirom Healthcare Technologies pay a dividend?
No. Medirom Healthcare Technologies has not paid a cash dividend over the last twelve months.
How has MRM stock performed over the past year?
Including dividends, MRM returned -86.6% over the past year, against +12.4% for the S&P 500.
Who are Medirom Healthcare Technologies's competitors?
Companies most similar to Medirom Healthcare Technologies by business, industry and size include WW, HRB, SCI, UNF, YELP.
See a number that looks wrong?